Prognostic Understanding for Older, Medically Infirm, and/or Frail Recipients of Allogeneic Hematopoietic Cell Transplantation in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)
Elizabeth T. Loggers(University of Washington), Mohamed L. Sorror(University of Washington Medical Center), Ronald Sobecks(Cleveland Clinic), Reena Jayani(Vanderbilt University Medical Center), Michael W. Rabow, Kyle Neale(Cleveland Clinic), Jason A. Webb(Oregon Health & Science University), Laura Johnston(City Of Hope National Medical Center), James Fausto(University of Washington), Hassan B. Alkhateeb(Mayo Clinic), Laura A. Schoenherr(University of California, San Francisco), Mei-Ean Yeow(Mayo Clinic in Arizona), Rachel J. Cook(Oregon Health & Science University), Diana Martins-Welch(Hofstra University), Laura S. Rhee(Mayo Clinic in Arizona), Matthew Givens(Fred Hutch Cancer Center), Jorge Garcés Ferrer(Universitat de València), Susan McInnes(Cleveland Clinic), George Carrum(Houston Methodist), Santiago Lopez(Hofstra University), Elisheva Newman(The Barbara Ann Karmanos Cancer Institute), Mark Juckett(UW Health University Hospital), Joseph P. Uberti(Sheba Medical Center), Drew A. Rosielle(University of Minnesota Medical Center)
Cited by 0
Related Papers
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
|JAMA Oncology|2021|464
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
|Journal of Clinical Oncology|2013|439
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435